TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients
Clinical trial NCT02414945 · COMPLETED
Trial details
- NCT number
- NCT02414945
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-15
- Primary completion
- 2020-10-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.